Literature DB >> 24970573

Annual atrial tachyarrhythmia burden determined by device interrogation in patients with cardiac implanted electronic devices is associated with a risk of ischaemic stroke independent of known risk factors.

Szu-Heng Wang1, Yu-Chuan Kang1, Chun-Chieh Wang2, Ming-Shien Wen2, Kuo-Chun Hung2, Chao-Yung Wang2, Tien-Hsing Chen3.   

Abstract

OBJECTIVES: This study evaluated the risk of non-fatal ischaemic stroke associated with increased long-term cumulative duration of atrial tachycardia (AT).
METHODS: We retrospectively reviewed the records of 260 patients with cardiovascular implantable electronic devices capable of monitoring AT. Patients were separated into zero, low and high AT burden groups. The cut-off point between low and high AT burden was defined by the median value of AT burden in the non-zero AT burden groups (5% in 1 year, about 18 days annually). The primary outcome was non-fatal ischaemic stroke.
RESULTS: The mean patient age was 63.3 ± 13.7 years, the average follow-up was 7.0 years and 10 patients had strokes. Multivariate analysis showed only hypertension and a diagnosis of atrial fibrillation (AF) were associated with stroke. The risk of stroke in patients with hypertension was 12.57-fold higher than in those without hypertension, and was 20.81-fold higher in patients with paroxysmal AF and 162.59-fold higher in patients with chronic AF than in those without AF. Kaplan-Meier analysis showed that stroke-free survival was significantly different in the three AT burden groups (P = 0.002, long-rank test); the rate was greatest in the zero AT burden group, followed by the low AT burden group and was lowest in the high AT burden group.
CONCLUSIONS: Patients who accumulated an AT duration exceeding 5% (18 days) of the total time in any of the 1-year periods are more likely to have an ischaemic stroke than those who have a low or zero AT burden.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Atrial tachyarrhythmia; Cardiac implantable device; Ischaemic stroke

Mesh:

Year:  2014        PMID: 24970573     DOI: 10.1093/ejcts/ezu252

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  National Trends in Ambulatory Oral Anticoagulant Use.

Authors:  Geoffrey D Barnes; Eleanor Lucas; G Caleb Alexander; Zachary D Goldberger
Journal:  Am J Med       Date:  2015-07-02       Impact factor: 4.965

2.  Continuous monitoring after atrial fibrillation ablation: the LINQ AF study.

Authors:  Simon Wechselberger; Mads Kronborg; Yan Huo; Judith Piorkowski; Sebastian Neudeck; Ellen Päßler; Ali El-Armouche; Utz Richter; Julia Mayer; Stefan Ulbrich; Liying Pu; Bettina Kirstein; Thomas Gaspar; Christopher Piorkowski
Journal:  Europace       Date:  2018-11-01       Impact factor: 5.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.